Strain sc|0025327

StrainInfo: SI-ID 15077 ^T

Taxon

Mycobacterium tuberculosis^T

Sample

Human-lung (US)

Cultures (11)

CT2008-03715 = ATCC 25618 = ATCC 27294 = CCUG 37357 = NCTC 7416 = CCUG 38148 = CIP 104475 = CIP 64.31 = ATCC 9360 = NCTC 13144 = CNCTC 7301

Other Designations (9)

H37Rv = ITM 500735 = 083715 = G.Kubica TMC 102 = KPM T021 = TMC 102 = Trudeau Inst. H37Rv = MG 1 = CNCTC My 331/88

Sequences (21)

• Gene Nucleotide:U06258
  Mycobacterium tuberculosis ATCC 25618 catalase (katG) gene, complete cds
• Gene Nucleotide:AY299144
  Mycobacterium tuberculosis strain ATCC 27294 heat shock protein 65 (hsp65) gene, partial cds
• rRNA Operon Nucleotide:FJ468345
  Mycobacterium tuberculosis strain ATCC 27294 16S ribosomal RNA gene, partial sequence
• Patent Nucleotide:AX590328
  Sequence 5 from Patent EP1254963
• Gene Nucleotide:AF060353
  Mycobacterium tuberculosis RNA polymerase beta-subunit (rpoB) gene, partial cds
• Gene Nucleotide:U06259
  Mycobacterium tuberculosis ATCC 27294 catalase (katG) gene, complete cds
• rRNA Operon Nucleotide:AF059845
  Mycobacterium tuberculosis 16S ribosomal RNA (rrs) gene, partial sequence
• rRNA Operon Nucleotide:JQ348114
  Mycobacterium tuberculosis H37Rv strain ATCC 27294 16S ribosomal RNA gene, partial sequence
• Gene Nucleotide:GQ247736
  Mycobacterium tuberculosis strain ATCC 27294 DNA gyrase subunit B (gyrB) gene, partial cds
• Gene Nucleotide:AF253444
  Mycobacterium tuberculosis alpha-crystallin protein (acr) gene, partial cds
• Gene Nucleotide:AY724732
  Mycobacterium tuberculosis strain ATCC 27294 preprotein translocase SecA1 (secA1) gene, partial cds
• Gene Nucleotide:JF491311
  Mycobacterium tuberculosis strain ATCC 27294 GroEL (hsp65) gene, partial cds
• Gene Nucleotide:AF057454
  Mycobacterium tuberculosis RNA polymerase beta (rpoB) gene, partial cds
• rRNA Operon Nucleotide:X58890
  M.tuberculosis ribosomal RNA operon encoding 16S and 23S ribosomal RNA
• rRNA Operon Nucleotide:AF547977
  Mycobacterium tuberculosis subsp. tuberculosis strain CIP 64.31 16S ribosomal RNA gene, partial sequence
• Gene Nucleotide:AF547886
  Mycobacterium tuberculosis subsp. tuberculosis strain CIP 64.31 65 kDa heat shock protein (hsp65) gene, partial cds
• Gene Nucleotide:EF686865
  Mycobacterium tuberculosis strain CIP 64.31 SmpB (smpB) gene, partial cds
• Gene Nucleotide:AY544974
  Mycobacterium tuberculosis subsp. tuberculosis strain CIP 64.31 RNA polymerase (rpoB) gene, partial cds
• Gene Nucleotide:DQ480269
  Mycobacterium tuberculosis strain CIP 64.31 tmRNA (ssrA) gene, partial sequence
• Gene Nucleotide:DQ986023
  Mycobacterium tuberculosis strain CIP 64.31 elongation factor Tu (tuf) gene, partial cds
• Gene Nucleotide:AY544875
  Mycobacterium tuberculosis subsp. tuberculosis strain CIP 64.31 superoxide dismutase (sod) gene, partial cds

Associated Publications (112)

• DOI: 10.1186/s13065-018-0435-0
  Yusufzai SK, Osman H, Khan MS, Abd Razik BM, Ezzat MO, Mohamad S, Sulaiman O, Gansau JA, Parumasivam T (2018). 4-Thiazolidinone coumarin derivatives as two-component NS2B/NS3 DENV flavivirus serine protease inhibitors: synthesis, molecular docking, biological evaluation and structure-activity relationship studies.
• DOI: 10.1093/clinids/11.supplement_2.s411
  Patel RJ, Piessens WF, David JR, Wirth DF (1989). A cloned DNA fragment for identification of Mycobacterium tuberculosis.
• DOI: 10.1128/JCM.01229-09
  Bravo LT, Tuohy MJ, Ang C, Destura RV, Mendoza M, Procop GW, Gordon SM, Hall GS, Shrestha NK (2009). Pyrosequencing for rapid detection of Mycobacterium tuberculosis resistance to rifampin, isoniazid, and fluoroquinolones.
• DOI: 10.1016/j.tube.2021.102156
  Rodriguez-Beltran E, Lopez GD, Anzola JM, Rodriguez-Castillo JG, Carazzone C, Murcia MI (2021). Heterogeneous fitness landscape cues, pknG low expression, and phthiocerol dimycocerosate low production of Mycobacterium tuberculosis ATCC25618 rpoB S450L in enriched broth.
• DOI: 10.2174/1573406418666220413095854
  Mahmoud HK, Sayed AR, Abdel-Aziz MM, Gomha SM (2022). Synthesis of New Thiazole Clubbed Imidazo[2,1-b]thiazole Hybrid as Antimycobacterial Agents.
• DOI: 10.1016/j.ejmech.2009.11.036
  Eswaran S, Adhikari AV, Ajay Kumar R (2009). New 1,3-oxazolo[4,5-c]quinoline derivatives: synthesis and evaluation of antibacterial and antituberculosis properties.
• Labidi A, Thoen CO (1989). Genetic relatedness among Mycobacterium tuberculosis and M. bovis.
• Labidi A (1988). Restriction endonuclease analysis of total deoxyribonucleic acid of Mycobacterium tuberculosis H37RV (ATCC 27294) and of M. bovis (ATCC 19210).
• DOI: 10.1128/jcm.33.5.1418-1420.1995
  Abed Y, Davin-Regli A, Bollet C, De Micco P (1995). Efficient discrimination of Mycobacterium tuberculosis strains by 16S-23S spacer region-based random amplified polymorphic DNA analysis.
• DOI: 10.1159/000007255
  van Rensburg CE, Joone GK, Sirgel FA, Matlola NM, O'Sullivan JF (2000). In vitro investigation of the antimicrobial activities of novel tetramethylpiperidine-substituted phenazines against Mycobacterium tuberculosis.
• DOI: 10.1002/ptr.724
  Asres K, Bucar F, Edelsbrunner S, Kartnig T, Hoger G, Thiel W (2001). Investigations on antimycobacterial activity of some Ethiopian medicinal plants.
• DOI: 10.1128/AAC.45.12.3631-3634.2001
  Chan CY, Au-Yeang C, Yew WW, Hui M, Cheng AF (2001). Postantibiotic effects of antituberculosis agents alone and in combination.
• DOI: 10.1016/s0968-0896(01)00310-8
  Cocco MT, Congiu C, Onnis V, Pellerano ML, De Logu A (2002). Synthesis and antimycobacterial activity of new S-alkylisothiosemicarbazone derivatives.
• DOI: 10.1093/jac/49.2.275
  De Logu A, Onnis V, Saddi B, Congiu C, Schivo ML, Cocco MT (2002). Activity of a new class of isonicotinoylhydrazones used alone and in combination with isoniazid, rifampicin, ethambutol, para-aminosalicylic acid and clofazimine against Mycobacterium tuberculosis.
• DOI: 10.1016/s0928-0987(02)00014-3
  Koketsu M, Tanaka K, Takenaka Y, Kwong CD, Ishihara H (2002). Synthesis of 1,3-thiazine derivatives and their evaluation as potential antimycobacterial agents.
• DOI: 10.1089/107662902760190707
  Ruiz P, Rodriguez-Cano F, Zerolo FJ, Casal M (2002). Investigation of the in vitro activity of streptomycin against Mycobacterium tuberculosis.
• DOI: 10.1055/s-0031-1299931
  Ulusoy N (2002). Synthesis and antituberculosis activity of cycloalkylidenehydrazide and 4-aza-1-thiaspiro[4.5]decan-3-one derivatives of imidazo[2,1-b]thiazole.
• DOI: 10.1002/ardp.200390019
  Gundersen LL, Negussie AH, Rise F, OStby OB (2003). Antimycobacterial activity of 1-substituted indolizines.
• DOI: 10.1089/107662903322286535
  Ruiz P, Rodriguez-Cano F, Zerolo FJ, Casal M (2003). Current interest of isoniazid in the chemotherapy of tuberculosis in the light of its in vitro activity.
• Ruiz P, Rodriguez-Cano F, Zerolo FJ, Casal M (2003). [Streptomycin as second-line chemotherapy for tuberculosis].
• DOI: 10.1128/AAC.48.1.340-343.2004
  Chan CY, Au-Yeang C, Yew WW, Leung CC, Cheng AF (2004). In vitro postantibiotic effects of rifapentine, isoniazid, and moxifloxacin against Mycobacterium tuberculosis.
• DOI: 10.1016/j.mimet.2003.10.020
  Thornton CG, MacLellan KM, Brink TL, Passen S (2004). Characterization of the susceptibility of mycobacteria in BACTEC 12B media containing PANTA that had been supplemented with ceftazidime, and characterization of the individual components of PANTA in the presence of C18-carboxypropylbetaine.
• Foroumadi A, Soltani F, Rezaee MA, Moshafi MH (2003). Synthesis and evaluation of in vitro antimycobacterial activity of some 5-(5-nitro-2-thienyl)-2-(piperazinyl, piperidinyl and morpholinyl)-1,3,4-thiadiazole derivatives.
• DOI: 10.1089/mdr.2004.10.239
  Ruiz P, Gutierrez J, Rodriguez-Cano F, Zerolo FJ, Casal M (2004). Activity of rifampin against Mycobacterium tuberculosis in a reference center.
• DOI: 10.1128/JCM.43.5.2471-2473.2005
  Aldous WK, Pounder JI, Cloud JL, Woods GL (2005). Comparison of six methods of extracting Mycobacterium tuberculosis DNA from processed sputum for testing by quantitative real-time PCR.
• DOI: 10.1080/14756360500043471
  Kaplancikli ZA, Turan-Zitouni G, Chevallet P (2005). Synthesis and antituberculosis activity of new 3-alkylsulfanyl-1,2,4-triazole derivatives.
• Bao JL, Le J, Tian YP, Yang YP, Wang HH (2005). [Protein profiling of human dendritic cells infected with mycobacterium tuberculosis].
• DOI: 10.1016/j.bmc.2005.05.011
  Macaev F, Rusu G, Pogrebnoi S, Gudima A, Stingaci E, Vlad L, Shvets N, Kandemirli F, Dimoglo A, Reynolds R (2005). Synthesis of novel 5-aryl-2-thio-1,3,4-oxadiazoles and the study of their structure-anti-mycobacterial activities.
• DOI: 10.1055/s-0031-1296708
  Bijev A (2006). Synthesis and preliminary screening of carbohydrazides and hydrazones of pyrrole derivatives as potential tuberculostatics.
• DOI: 10.1016/j.bmc.2006.08.019
  Costa MS, Boechat N, Rangel EA, da Silva Fde C, de Souza AM, Rodrigues CR, Castro HC, Junior IN, Lourenco MC, Wardell SM, Ferreira VF (2006). Synthesis, tuberculosis inhibitory activity, and SAR study of N-substituted-phenyl-1,2,3-triazole derivatives.
• DOI: 10.1002/ptr.2119
  Duarte N, Ferreira MJ, Martins M, Viveiros M, Amaral L (2007). Antibacterial activity of ergosterol peroxide against Mycobacterium tuberculosis: dependence upon system and medium employed.
• DOI: 10.1016/j.ejmech.2007.07.001
  Turan-Zitouni G, Ozdemir A, Kaplancikli ZA, Benkli K, Chevallet P, Akalin G (2007). Synthesis and antituberculosis activity of new thiazolylhydrazone derivatives.
• DOI: 10.1080/14756360601178424
  Ozdemir A, Turan-Zitouni G, Kaplancikli ZA, Chevallet P (2007). Synthesis of some 4-arylidenamino-4H-1,2,4-triazole-3-thiols and their antituberculosis activity.
• Martins M, Viveiros M, Amaral L (2008). Inhibitors of Ca2+ and K+ transport enhance intracellular killing of M. tuberculosis by non-killing macrophages.
• DOI: 10.1002/ardp.200800048
  Kaplancikli ZA, Turan-Zitouni G, Ozdemir A, Teulade JC (2008). Synthesis and antituberculosis activity of new hydrazide derivatives.
• Husain A, Alam MM, Hasan SM, Yar MS (2009). 2(3H)-furanones and 2(3H)-pyrrolones: synthesis and antimycobacterial evaluation.
• DOI: 10.1016/j.ejmech.2009.08.009
  Vergara FM, Lima CH, Henriques Md, Candea AL, Lourenco MC, Ferreira Mde L, Kaiser CR, de Souza MV (2009). Synthesis and antimycobacterial activity of N'-[(E)-(monosubstituted-benzylidene)]-2-pyrazinecarbohydrazide derivatives.
• DOI: 10.1021/ic901039k
  Asmafiliz N, Kilic Z, Ozturk A, Hokelek T, Koc LY, Acik L, Kisa O, Albay A, Ustundag Z, Solak AO (2009). Phosphorus-nitrogen compounds. 18. Syntheses, stereogenic properties, structural and electrochemical investigations, biological activities, and DNA interactions of new spirocyclic mono- and bisferrocenylphosphazene derivatives.
• DOI: 10.1016/j.ejmech.2009.09.024
  Guzeldemirci NU, Kucukbasmaci O (2009). Synthesis and antimicrobial activity evaluation of new 1,2,4-triazoles and 1,3,4-thiadiazoles bearing imidazo[2,1-b]thiazole moiety.
• DOI: 10.1099/jmm.0.014837-0
  Ge F, Zeng F, Liu S, Guo N, Ye H, Song Y, Fan J, Wu X, Wang X, Deng X, Jin Q, Yu L (2010). In vitro synergistic interactions of oleanolic acid in combination with isoniazid, rifampicin or ethambutol against Mycobacterium tuberculosis.
• DOI: 10.1002/ardp.200900162
  Ferreira SB, de Carvalho da Silva F, Bezerra FA, Lourenco MC, Kaiser CR, Pinto AC, Ferreira VF (2010). Synthesis of alpha- and beta-pyran naphthoquinones as a new class of antitubercular agents.
• DOI: 10.1002/ardp.200900216
  Fernandes JP, Pasqualoto KF, Felli VM, Ferreira EI, Brandt CA (2010). QSAR modeling of a set of pyrazinoate esters as antituberculosis prodrugs.
• DOI: 10.1016/j.ejmech.2010.01.017
  Turan-Zitouni G, Kaplancikli ZA, Ozdemir A (2010). Synthesis and antituberculosis activity of some N-pyridyl-N'-thiazolylhydrazine derivatives.
• DOI: 10.1515/znc-2009-11-1204
  Silva ML, Martins CH, Lucarini R, Sato DN, Pavanb FR, Freitas NH, Andrade LN, Pereira AC, Bianco TN, Vinholis AH, Cunha WR, Bastos JK, Silva R, Da Silva Filho AA (2009). Antimycobacterial activity of natural and semi-synthetic lignans.
• DOI: 10.1016/j.tube.2010.06.001
  Coelho TS, Silva RS, Pinto AV, Pinto MC, Scaini CJ, Moura KC, Almeida da Silva P (2010). Activity of beta-lapachone derivatives against rifampicin-susceptible and -resistant strains of Mycobacterium tuberculosis.
• DOI: 10.1016/j.jinorgbio.2010.07.005
  Tarallo MB, Urquiola C, Monge A, Costa BP, Ribeiro RR, Costa-Filho AJ, Mercader RC, Pavan FR, Leite CQ, Torre MH, Gambino D (2010). Design of novel iron compounds as potential therapeutic agents against tuberculosis.
• DOI: 10.1016/j.ejmech.2011.02.003
  Sirisha K, Bikshapathi D, Achaiah G, Reddy VM (2011). Synthesis, antibacterial and antimycobacterial activities of some new 4-aryl/heteroaryl-2,6-dimethyl-3,5-bis-N-(aryl)-carbamoyl-1,4-dihydropyridines.
• DOI: 10.1093/jac/dkr057
  Campanerut PA, Ghiraldi LD, Spositto FL, Sato DN, Leite CQ, Hirata MH, Hirata RD, Cardoso RF (2011). Rapid detection of resistance to pyrazinamide in Mycobacterium tuberculosis using the resazurin microtitre assay.
• DOI: 10.1111/j.1747-0285.2011.01120.x
  Cardoso SH, Barreto MB, Lourenco MC, Henriques Md, Candea AL, Kaiser CR, de Souza MV (2011). Antitubercular activity of new coumarins.
• DOI: 10.1111/j.1469-0691.2011.03508.x
  Ghiraldi LD, Campanerut PA, Spositto FL, Sato DN, Leite CQ, Hirata M, Hirata RD, Cardoso RF (2011). Evaluation of the microscopic observation drug susceptibility assay for detection of Mycobacterium tuberculosis resistance to pyrazinamide.
• DOI: 10.1021/jm2003624
  Boechat N, Ferreira VF, Ferreira SB, de Lourdes G Ferreira M, de C da Silva F, Bastos MM, Dos S Costa M, Lourenco MC, Pinto AC, Krettli AU, Aguiar AC, Teixeira BM, da Silva NV, Martins PR, Bezerra FA, Camilo AL, da Silva GP, Costa CC (2011). Novel 1,2,3-triazole derivatives for use against Mycobacterium tuberculosis H37Rv (ATCC 27294) strain.
• DOI: 10.3109/03639045.2011.598535
  Minarini PR, de Souza AO, Soares EG, Barata LE, Silva CL, Bentley MV (2011). Antimycobacterial activity of 2-phenoxy-1-phenylethanone, a synthetic analogue of neolignan, entrapped in polymeric microparticles.
• DOI: 10.1007/s12272-013-0062-1
  Raja S, Prakash CR (2013). Novel 1-(4-substituted benzylidene)-4-(1-(substituted methyl)-2,3-dioxoindolin-5-yl)semicarbazide derivatives for use against Mycobacterium tuberculosis H37Rv (ATCC 27294) and MDR-TB strain.
• DOI: 10.1186/1472-6882-13-81
  Fouotsa H, Mbaveng AT, Mbazoa CD, Nkengfack AE, Farzana S, Iqbal CM, Meyer JJ, Lall N, Kuete V (2013). Antibacterial constituents of three Cameroonian medicinal plants: Garcinia nobilis, Oricia suaveolens and Balsamocitrus camerunensis.
• DOI: 10.1016/j.jep.2013.06.022
  Mehta A, Srivastva G, Kachhwaha S, Sharma M, Kothari SL (2013). Antimycobacterial activity of Citrullus colocynthis (L.) Schrad. against drug sensitive and drug resistant Mycobacterium tuberculosis and MOTT clinical isolates.
• DOI: 10.1016/j.tube.2013.09.001
  Caleffi-Ferracioli KR, Maltempe FG, Siqueira VL, Cardoso RF (2013). Fast detection of drug interaction in Mycobacterium tuberculosis by a checkerboard resazurin method.
• DOI: 10.1016/j.bmc.2013.09.034
  Rodrigues MO, Cantos JB, D'Oca CR, Soares KL, Coelho TS, Piovesan LA, Russowsky D, da Silva PA, D'Oca MG (2013). Synthesis and antimycobacterial activity of isoniazid derivatives from renewable fatty acids.
• DOI: 10.1016/j.ejmech.2013.10.082
  Yempala T, Sridevi JP, Yogeeswari P, Sriram D, Kantevari S (2013). Rational design and synthesis of novel dibenzo[b,d]furan-1,2,3-triazole conjugates as potent inhibitors of Mycobacterium tuberculosis.
• DOI: 10.1111/lam.12195
  Guo N, Wu J, Fan J, Yuan P, Shi Q, Jin K, Cheng W, Zhao X, Zhang Y, Li W, Tang X, Yu L (2013). In vitro activity of isoimperatorin, alone and in combination, against Mycobacterium tuberculosis.
• DOI: 10.1128/JCM.00065-14
  Chen X, Wang B, Yang W, Kong F, Li C, Sun Z, Jelfs P, Gilbert GL (2014). Rolling circle amplification for direct detection of rpoB gene mutations in Mycobacterium tuberculosis isolates from clinical specimens.
• DOI: 10.1016/j.bmcl.2014.02.061
  Addla D, Jallapally A, Gurram D, Yogeeswari P, Sriram D, Kantevari S (2014). Design, synthesis and evaluation of 1,2,3-triazole-adamantylacetamide hybrids as potent inhibitors of Mycobacterium tuberculosis.
• DOI: 10.1016/j.jsps.2013.12.005
  Fernandes JP, Pavan FR, Leite CQ, Felli VM (2013). Synthesis and evaluation of a pyrazinoic acid prodrug in Mycobacterium tuberculosis.
• DOI: 10.1016/j.ejmech.2014.09.067
  Machado I, Marino LB, Demoro B, Echeverria GA, Piro OE, Leite CQ, Pavan FR, Gambino D (2014). Bioactivity of pyridine-2-thiolato-1-oxide metal complexes: Bi(III), Fe(III) and Ga(III) complexes as potent anti-Mycobacterium tuberculosis prospective agents.
• Esfahani BN, Hozoorbakhsh F, Rashed Kh, Havaei SA, Heidari K, Moghim Sh (2014). Effect of Lagerstroemia tomentosa and Diospyros virginiana methanolic extracts on different drug-resistant strains of Mycobacterium tuberculosis.
• DOI: 10.2147/DDDT.S83047
  Revathi R, Venkatesha Perumal R, Pai KS, Arunkumar G, Sriram D, Kini SG (2015). Design, development, drug-likeness, and molecular docking studies of novel piperidin-4-imine derivatives as antitubercular agents.
• DOI: 10.1007/s10096-016-2625-9
  Lin SY, Hwang SC, Yang YC, Wang CF, Chen YH, Chen TC, Lu PL (2016). Early detection of Mycobacterium tuberculosis complex in BACTEC MGIT cultures using nucleic acid amplification.
• DOI: 10.4103/2277-9175.180991
  Hozoorbakhsh F, Esfahani BN, Moghim S, Asghari G (2016). Evaluation of the effect of Pulicaria gnaphalodes and Perovskia abrotanoides essential oil extracts against Mycobacterium tuberculosis strains.
• DOI: 10.3390/ijms17050745
  Silva PB, Souza PC, Calixto GM, Lopes Ede O, Frem RC, Netto AV, Mauro AE, Pavan FR, Chorilli M (2016). In Vitro Activity of Copper(II) Complexes, Loaded or Unloaded into a Nanostructured Lipid System, against Mycobacterium tuberculosis.
• DOI: 10.1016/j.bmcl.2016.07.039
  Sajja Y, Vanguru S, Jilla L, Vulupala HR, Bantu R, Yogeswari P, Sriram D, Nagarapu L (2016). A convenient synthesis and screening of benzosuberone bearing 1,2,3-triazoles against Mycobacterium tuberculosis.
• DOI: 10.1016/j.ejmech.2016.07.039
  Fernandes GFDS, de Souza PC, Marino LB, Chegaev K, Guglielmo S, Lazzarato L, Fruttero R, Chung MC, Pavan FR, Dos Santos JL (2016). Synthesis and biological activity of furoxan derivatives against Mycobacterium tuberculosis.
• DOI: 10.1007/s10534-016-9968-7
  Firmino GS, de Souza MV, Pessoa C, Lourenco MC, Resende JA, Lessa JA (2016). Synthesis and evaluation of copper(II) complexes with isoniazid-derived hydrazones as anticancer and antitubercular agents.
• Santoro F, Guerrini V, Lazzeri E, Iannelli F, Pozzi G (2016). Genomic polymorphisms in a Laboratory Isolate of Mycobacterium tuberculosis Reference Strain H37Rv (ATCC27294).
• DOI: 10.1016/j.bmcl.2016.10.082
  Tanwar B, Kumar A, Yogeeswari P, Sriram D, Chakraborti AK (2016). Design, development of new synthetic methodology, and biological evaluation of substituted quinolines as new anti-tubercular leads.
• DOI: 10.2174/1573406413666170209144003
  Soares A, Estevao MS, Marques MMB, Kovalishyn V, Latino DARS, Aires-de-Sousa J, Ramos J, Viveiros M, Martins F (2017). Synthesis and Biological Evaluation of Hybrid 1,5- and 2,5-Disubstituted Indoles as Potentially New Antitubercular Agents.
• DOI: 10.1111/cbdd.12969
  Sajja Y, Vanguru S, Vulupala HR, Nagarapu L, Perumal Y, Sriram D, Nanubolu JB (2017). Design, synthesis, and in vitro antituberculosis activity of benzo[6,7]cyclohepta[1,2-b]pyridine-1,3,4-oxadiazole derivatives.
• DOI: 10.1016/j.ejmech.2017.03.015
  Jose G, Suresha Kumara TH, Sowmya HBV, Sriram D, Guru Row TN, Hosamani AA, More SS, Janardhan B, Harish BG, Telkar S, Ravikumar YS (2017). Synthesis, molecular docking, antimycobacterial and antimicrobial evaluation of new pyrrolo[3,2-c]pyridine Mannich bases.
• DOI: 10.1016/j.jinorgbio.2017.04.024
  Paixao DA, Marzano IM, Jaimes EHL, Pivatto M, Campos DL, Pavan FR, Deflon VM, Maia PIDS, Da Costa Ferreira AM, Uehara IA, Silva MJB, Botelho FV, Pereira-Maia EC, Guilardi S, Guerra W (2017). Novel copper(II) complexes with hydrazides and heterocyclic bases: Synthesis, structure and biological studies.
• DOI: 10.1186/s12906-017-1818-9
  Fadipe VO, Mongalo NI, Opoku AR, Dikhoba PM, Makhafola TJ (2017). Isolation of anti-mycobacterial compounds from Curtisia dentata (Burm.f.) C.A.Sm (Curtisiaceae).
• DOI: 10.1007/s11030-017-9779-y
  Dongamanti A, Aamate VK, Devulapally MG, Gundu S, Balabadra S, Manga V, Yogeeswari P, Sriram D, Balasubramanian S (2017). Bis-spirochromanones as potent inhibitors of Mycobacterium tuberculosis: synthesis and biological evaluation.
• DOI: 10.1016/j.mcp.2017.08.004
  Ma Q, Liu H, Ye F, Xiang G, Shan W, Xing W (2017). Rapid and visual detection of Mycobacterium tuberculosis complex using recombinase polymerase amplification combined with lateral flow strips.
• DOI: 10.1080/13880200590951829
  Lall N, Meyer JJM, Wang Y, Bapela NB, van Rensburg CEJ, Fourie B, Franzblau SG (2005). Characterization of Intracellular Activity of Antitubercular Constituents the Roots of Euclea natalensis.
• DOI: 10.1016/j.bmcl.2017.10.071
  Sajja Y, Vanguru S, Vulupala HR, Bantu R, Yogeswari P, Sriram D, Nagarapu L (2017). Design, synthesis and in vitro anti-tuberculosis activity of benzo[6,7]cyclohepta[1,2-b]pyridine-1,2,3-triazole derivatives.
• Nandha B, Nargund LG, Nargund SL, Bhat K (2017). Design and Synthesis of Some Novel Fluorobenzimidazoles Substituted with Structural Motifs Present in Physiologically Active Natural Products for Antitubercular Activity.
• DOI: 10.1016/j.jinorgbio.2018.03.010
  de Oliveira LP, Carneiro ZA, Ribeiro CM, Lima MF, Paixao DA, Pivatto M, de Souza MVN, Teixeira LR, Lopes CD, de Albuquerque S, Pavan FR, Guerra W (2018). Three new platinum complexes containing fluoroquinolones and DMSO: Cytotoxicity and evaluation against drug-resistant tuberculosis.
• DOI: 10.1111/cbdd.13196
  Banu S, Bollu R, Nagarapu L, Nanubolu JB, Yogeswari P, Sriram D, Gunda SK, Vardhan D (2018). Design, Synthesis, and in vitro antitubercular activity of 1,2,3-triazolyl-dihydroquinoline derivatives.
• DOI: 10.1111/cbdd.13315
  de Castro PP, Campos DL, Pavan FR, Amarante GW (2018). Dual-protected amino acid derivatives as new antitubercular agents.
• DOI: 10.3389/fmicb.2018.00673
  Halicki PCB, Ferreira LA, De Moura KCG, Carneiro PF, Del Rio KP, Carvalho TDSC, Pinto MDCFR, da Silva PEA, Ramos DF (2018). Naphthoquinone Derivatives as Scaffold to Develop New Drugs for Tuberculosis Treatment.
• DOI: 10.1016/j.steroids.2018.09.006
  Agarwal DS, Siva Krishna V, Sriram D, Yogeeswari P, Sakhuja R (2018). Clickable conjugates of bile acids and nucleosides: Synthesis, characterization, in vitro anticancer and antituberculosis studies.
• DOI: 10.1007/s13205-018-1450-5
  Sasikumar K, Ghosh AR, Dusthackeer A (2018). Antimycobacterial potentials of quercetin and rutin against Mycobacterium tuberculosis H37Rv.
• DOI: 10.1007/s11033-018-4424-0
  Trenado-Uribe M, Silva-Miranda M, Rivero-Cruz JF, Rodriguez-Pena K, Espitia-Pinzon CI, Rodriguez-Sanoja R, Sanchez S (2018). Antimycobacterial activity of an anthracycline produced by an endophyte isolated from Amphipterygium adstringens.
• DOI: 10.2174/1568026619666190304124952
  da Silva Araujo A, Moraes AM, Lourenco MCS, Pessoa CO, da Silva ET, de Souza MVN (2019). Synthesis and Antibacterial Activity of Mefloquine-Based Analogs Against Sensitive and Resistant Mycobacterium tuberculosis Strains.
• DOI: 10.1038/s41429-019-0243-3
  Campos DL, Machado I, Ribeiro CM, Gambino D, Pavan FR (2019). Bactericidal effect of pyridine-2-thiol 1-oxide sodium salt and its complex with iron against resistant clinical isolates of Mycobacterium tuberculosis.
• DOI: 10.1016/j.bioorg.2020.103626
  Marvadi SK, Krishna VS, Surineni G, Srilakshmi Reshma R, Sridhar B, Sriram D, Kantevari S (2020). Synthesis, in vitro, and in vivo (Zebra fish) antitubercular activity of 7,8-dihydroquinolin-5(6H)-ylidenehydrazinecarbothioamides.
• DOI: 10.1007/s00706-019-02457-9
  Cihan-Ustundag G, Naesens L, Satana D, Erkose-Genc G, Mataraci-Kara E, Capan G (2019). Design, synthesis, antitubercular and antiviral properties of new spirocyclic indole derivatives.
• DOI: 10.1007/s00044-013-0787-x
  Kumar SB, Ravinder M, Kishore G, Jayathirtha Rao V, Yogeeswari P, Sriram D (2013). Synthesis, antitubercular and anticancer activity of new Baylis-Hillman adduct-derived N-cinnamyl-substituted isatin derivatives.
• DOI: 10.1007/s11030-020-10108-z
  Dogamanti A, Chiranjeevi P, Aamate VK, Vagolu SK, Sriram D, Balasubramanian S, Sarasija M (2020). Indole-fused spirochromenes as potential anti-tubercular agents: design, synthesis and in vitro evaluation.
• DOI: 10.1016/j.cmi.2020.07.036
  Schon T, Werngren J, Machado D, Borroni E, Wijkander M, Lina G, Mouton J, Matuschek E, Kahlmeter G, Giske C, Santin M, Cirillo DM, Viveiros M, Cambau E (2020). Antimicrobial susceptibility testing of Mycobacterium tuberculosis complex isolates - the EUCAST broth microdilution reference method for MIC determination.
• DOI: 10.1016/j.ejmech.2020.112859
  Ribeiro RCB, de Marins DB, Di Leo I, da Silva Gomes L, de Moraes MG, Abbadi BL, Villela AD, da Silva WF, da Silva LCRP, Machado P, Bizarro CV, Basso LA, Cristina de Moraes M, Ferreira VF, da Silva FC, Nascimento V (2020). Anti-tubercular profile of new selenium-menadione conjugates against Mycobacterium tuberculosis H37Rv (ATCC 27294) strain and multidrug-resistant clinical isolates.
• DOI: 10.1016/j.ejps.2020.105596
  da Silva ET, de Andrade GF, Araujo ADS, Lourenco MCS, de Souza MVN (2020). Antibacterial activity of new substituted 4-N-alkylated-2-trifluoromethyl-quinoline analogues against sensitive and resistant Mycobacterium tuberculosis strains.
• DOI: 10.1016/j.cmi.2020.10.019
  Schon T, Werngren J, Machado D, Borroni E, Wijkander M, Lina G, Mouton J, Matuschek E, Kahlmeter G, Giske C, Santin M, Cirillo DM, Viveiros M, Cambau E (2020). Multicentre testing of the EUCAST broth microdilution reference method for MIC determination on Mycobacterium tuberculosis.
• DOI: 10.1016/j.bioorg.2020.104538
  Dhameliya TM, Patel KI, Tiwari R, Vagolu SK, Panda D, Sriram D, Chakraborti AK (2020). Design, synthesis, and biological evaluation of benzo[d]imidazole-2-carboxamides as new anti-TB agents.
• DOI: 10.1080/14756366.2020.1868450
  Elsayed ZM, Eldehna WM, Abdel-Aziz MM, El Hassab MA, Elkaeed EB, Al-Warhi T, Abdel-Aziz HA, Abou-Seri SM, Mohammed ER (2021). Development of novel isatin-nicotinohydrazide hybrids with potent activity against susceptible/resistant Mycobacterium tuberculosis and bronchitis causing-bacteria.
• DOI: 10.3389/fcimb.2021.656880
  Bajaj AO, Saraswat S, Knuuttila JEA, Freeke J, Stielow JB, Barker AP (2021). Accurate Identification of Closely Related Mycobacterium tuberculosis Complex Species by High Resolution Tandem Mass Spectrometry.
• DOI: 10.3389/fcimb.2021.681131
  Medina-Alarcon KP, Tobias da Silva IP, Ferin GG, Pereira-da-Silva MA, Marcos CM, Dos Santos MB, Regasini LO, Chorilli M, Mendes-Giannini MJS, Pavan FR, Fusco-Almeida AM (2021). Mycobacterium tuberculosis and Paracoccidioides brasiliensis Formation and Treatment of Mixed Biofilm In Vitro.
• DOI: 10.1038/s41429-022-00520-y
  Yang R, Cao W, Liu S, Li Q, Sun Y, Liang C, Ren W, Liu Y, Meng J, Li C (2022). Evaluation of a novel inhibitor of aspartate semialdehyde dehydrogenase as a potent antitubercular agent against Mycobacterium tuberculosis.
• DOI: 10.5455/medarh.2022.76.248-251
  Singh B, Wasita B, Reviono R (2022). Kinetics of Granuloma, IFN-gamma and IP-10 in a Wistar Rat Model Infected with Mycobacterium Tuberculosis.
• DOI: 10.1128/spectrum.00319-23
  Yildirim K, Atas C, Simsek E, Coban AY (2023). The Effect of Inoculum Size on Antimicrobial Susceptibility Testing of Mycobacterium tuberculosis.
• DOI: 10.1038/s41598-023-49576-2
  Obiedallah MM, Mironov MA, Belyaev DV, Ene A, Vakhrusheva DV, Krasnoborova SY, Bershitsky SY, Shchepkin DV, Minin AS, Ishmetova RI, Ignatenko NK, Tolshchina SG, Fedorova OV, Rusinov GL (2024). Optimization, characterization, and cytotoxicity studies of novel anti-tubercular agent-loaded liposomal vesicles.
• DOI: 10.1111/cbdd.14512
  Tiwari P, Mangubhai GS, Kidwai S, Singh R, Chandrashekharappa S (2024). Design, synthesis and characterization of ethyl 3-benzoyl-7-morpholinoindolizine-1-carboxylate as anti-tubercular agents: In silico screening for possible target identification.
• DOI: 10.1016/j.mex.2024.102690
  Osorio-Gonzalez A, Alvarez N, Realpe T, Robledo J (2024). Protocol for the selection of Mycobacterium tuberculosis spontaneous resistant mutants to d-cycloserine.
• DOI: 10.1016/s0195-6701(99)90048-8
  Griffiths PA, Babb JR, Fraise AP (1999). Mycobactericidal activity of selected disinfectants using a quantitative suspension test.
• DOI: 10.1128/AAC.43.8.1866
  Billington OJ, McHugh TD, Gillespie SH (1999). Physiological cost of rifampin resistance induced in vitro in Mycobacterium tuberculosis.

Outside links and data sources

• StrainInfo DOI: 10.60712/SI-ID15077.3

Retrieved about 1 month ago via StrainInfo API (CC BY 4.0)

Metadata

Cannonical URL

https://seqco.de/s:25327

Local history

• Registered 8 months ago
• Last modified about 1 month ago